Administrative
行政的
基本信息
- 批准号:10713714
- 负责人:
- 金额:$ 8.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-19 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAlpha Particle EmitterAreaAwarenessBasic ScienceClinical ResearchCollaborationsCommunitiesExposure toFacultyFosteringFundingGoalsGroup MeetingsImageIndustryInternshipsLeadershipOccupational activity of managing financesOutcomePreparationProgress ReportsRadiobiologyRadiopharmaceuticalsResearch ActivityResearch PersonnelResearch Project GrantsResource SharingScheduleScientistServicesStudentsTrainingTranslational ResearchUniversitiesWorkclinical implementationclinically relevantdata exchangedosimetryexperienceinterestmeetingsmembernext generationprogramsstudent participationsummer internshipsummer student
项目摘要
Project Summary
The Administrative Core is responsible for the managerial oversight of the P01. This includes all administrative
and budgetary matters, scheduling advisory committee meetings as well as regular meetings of all project in-
vestigators. This Core will also work to assure that the direction and focus is periodically examined with an eye
towards clinical relevance and implementation. Reflecting the PIs interest in increasing diversity and training
the next generation of scientists in areas related to radiopharmaceutical therapy (RPT), this core will encour-
age and facilitate internships, summer student engagement, and other opportunities to expose students (at all
levels) to the work performed in the cores and projects. Specifically, this core will Aim 1: Provide overall scien-
tific leadership and managerial oversight of the P01, including integration of research activities across the pro-
jects and cores. Aim 2: Encourage scientific rigor and maintain focus on clinical relevance. Aim 3: Increase
diversity and encourage student engagement. Through these functions, the Administrative Core will provide an
essential service to each of the Research Projects and Cores to help accomplish the proposed goals and ob-
jectives of the P01. The longer-term administrative objective of this core and the overall program PI is to foster
interactions and collaborations that will endure beyond the P01 period and lead to breakthroughs in basic,
translational, and clinical research in imaging, dosimetry, and radiobiology of α-particle emitter radiopharma-
ceutical therapy.
项目摘要
行政核心负责P01的管理监督。其中包括所有行政
和预算事宜,安排咨询委员会会议,以及所有项目的定期会议-
调查员这一核心也将工作,以确保方向和重点是定期检查与眼睛
临床相关性和实施。反映PI对增加多样性和培训的兴趣
放射性药物治疗(RPT)相关领域的下一代科学家,这一核心将鼓励-
年龄和促进实习,暑期学生参与,以及其他机会,以接触学生(在所有
级别)与核心和项目中执行的工作相关联。具体而言,这一核心将实现目标1:提供全面的科学知识,
P01的有效领导和管理监督,包括整合专业领域的研究活动,
核心和核心。目标2:鼓励科学严谨性,并保持对临床相关性的关注。目标3:提高
多样性,鼓励学生参与。通过这些职能,行政核心将提供
为每个研究项目和核心提供必要的服务,以帮助实现拟议的目标和目标,
P01的缩写。这一核心和整体计划PI的长期管理目标是促进
互动和合作,将持续超过P01时期,并导致突破的基本,
在α粒子发射体放射性肿瘤的成像、剂量测定和放射生物学方面的转化和临床研究,
药物治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George Sgouros其他文献
George Sgouros的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George Sgouros', 18)}}的其他基金
Imaging, Dosimetry and Radiobiology for α-particle Emitter Radiopharmaceutical Therapy
α 粒子发射器放射性药物治疗的成像、剂量测定和放射生物学
- 批准号:
10713709 - 财政年份:2023
- 资助金额:
$ 8.99万 - 项目类别:
Combined Biologic and Radiopharmaceutical Therapy of Breast Cancer
乳腺癌的生物和放射药物联合治疗
- 批准号:
8914075 - 财政年份:2015
- 资助金额:
$ 8.99万 - 项目类别:
Combined Biologic and Radiopharmaceutical Therapy of Breast Cancer
乳腺癌的生物和放射药物联合治疗
- 批准号:
9261492 - 财政年份:2015
- 资助金额:
$ 8.99万 - 项目类别:
相似海外基金
Alpha-Particle Emitter Radiopharmaceutical Therapy for Liver Cancer
肝癌的α粒子发射放射性药物治疗
- 批准号:
10531240 - 财政年份:2019
- 资助金额:
$ 8.99万 - 项目类别:
Alpha-Particle Emitter Peptide Receptor Targeted Radionuclide Therapy for Neuroendocrine Tumors
α粒子发射肽受体靶向放射性核素治疗神经内分泌肿瘤
- 批准号:
10673599 - 财政年份:2019
- 资助金额:
$ 8.99万 - 项目类别:
Alpha-Particle Emitter Peptide Receptor Targeted Radionuclide Therapy for Neuroendocrine Tumors
α粒子发射肽受体靶向放射性核素治疗神经内分泌肿瘤
- 批准号:
10152579 - 财政年份:2019
- 资助金额:
$ 8.99万 - 项目类别:
Alpha-Particle Emitter Radiopharmaceutical Therapy for Liver Cancer
肝癌的α粒子发射放射性药物治疗
- 批准号:
10305102 - 财政年份:2019
- 资助金额:
$ 8.99万 - 项目类别:
Alpha-Particle Emitter Radiopharmaceutical Therapy for Liver Cancer
肝癌的α粒子发射放射性药物治疗
- 批准号:
10394421 - 财政年份:2019
- 资助金额:
$ 8.99万 - 项目类别:
Alpha-Particle Emitter Radiopharmaceutical Therapy for Liver Cancer
肝癌的α粒子发射放射性药物治疗
- 批准号:
9884219 - 财政年份:2019
- 资助金额:
$ 8.99万 - 项目类别:
Alpha-Particle Emitter Peptide Receptor Targeted Radionuclide Therapy for Neuroendocrine Tumors
α粒子发射肽受体靶向放射性核素治疗神经内分泌肿瘤
- 批准号:
10396517 - 财政年份:2019
- 资助金额:
$ 8.99万 - 项目类别:
Targeted Alpha-Particle Emitter Therapy of Metastases
转移瘤的靶向阿尔法粒子发射治疗
- 批准号:
7156165 - 财政年份:2005
- 资助金额:
$ 8.99万 - 项目类别:
Targeted Alpha-Particle Emitter Therapy of Metastases
转移瘤的靶向阿尔法粒子发射治疗
- 批准号:
7317817 - 财政年份:2005
- 资助金额:
$ 8.99万 - 项目类别:
Targeted Alpha-Particle Emitter Therapy of Metastases
转移瘤的靶向阿尔法粒子发射治疗
- 批准号:
7033111 - 财政年份:2005
- 资助金额:
$ 8.99万 - 项目类别: